★ Sexual Health

Melanotan II

Sexual Health · 10mg × 10 vials

In plain terms: Melanotan II is a research compound - oral, fast-acting and well studied.

✓ 98%+ Purity ✓ Lab Tested ✓ COA on Request ✓ Discreet Shipping ✓ Direct Support
📋 Certificate of Analysis Request the third-party COA via Telegram
Quick Start
🧪
Format
Injectable (reconstituted) · 10mg × 10 vials
🎯
Who it's for
fair-skinned users wanting deeper/easier tan
💉
How it's run
250 mcg SubQ daily during loading phase
When you'll notice
1-2 weeks
Pricing
$95from · kit of 10
In US stock · 2-5 day UPS 2nd Day Air
+ $40 ship · singles $20 · free over $1k per tier
10mg × 10 vials$95 / $39 single
Order / Consult on Telegram →
~30-60 min (plasma); pigmentation effect persists weeks
Half-life
loading + maintenance / seasonal
Cycling
1-2 weeks
First effects
sexual-health
Class
Overview

What Is Melanotan II?

Melanotan II is a synthetic cyclic heptapeptide analog of endogenous alpha-melanocyte stimulating hormone (alpha-MSH). It's a non-selective melanocortin receptor agonist, hitting MC1R, MC3R, MC4R, and MC5R. The tanning effect comes from MC1R activation on melanocytes in the skin, which upregulates eumelanin synthesis (the dark pigment) and shifts the melanocyte's output away from the lighter pheomelanin. UV exposure still has to do the actual triggering of tan formation, MT2 just turns up the gain on the response, so users tan faster, deeper, and with less sun damage required for a given level of pigmentation. The libido/spontaneous-erection side effect is driven by MC4R activation in the central nervous system, the same receptor PT-141/Vyleesi targets selectively. The nausea, flushing, and yawning are MC3R/MC4R crossover effects. MT2 was originally synthesized in the 1980s by Mac Hadley and Victor Hruby's lab at the University of Arizona, Tucson, as part of a research program looking for a sunless-tanning agent that could reduce melanoma risk in fair-skinned populations. It was never developed into an approved drug, the patent expired, and it became one of the original gray-market research peptides. PT-141 (bremelanotide) was synthesized from MT2 by stripping the tanning function and keeping the sexual-response arm; MT2 is essentially the older, broader cousin that does both at once.

Protocols

Typical dose ranges by experience level - educational reference. Message us and we tailor it to you.

Protocol250 mcg SubQ daily during loading phase
Frequencydaily for the first 1-2 weeks, then daily through the rest of the 4-8 week loading phase
Duration4-8 week loading phase to build pigmentation, then transition to maintenance. Total cycle length is usually seasonal (run spring through summer, off in winter).

250 mcg is the smallest dose that produces a meaningful response. Nausea, flushing, and yawning hit hardest on the first 2-3 doses and tachyphylax fast (the side effect adapts faster than the desired effect), so first-timers should pin at bedtime to sleep through the worst of it. At 5 mg/ml recon (10 mg vial + 2 ml BAC), 250 mcg = 5 IU on a U-100 pin, 500 mcg = 10 IU. Jordan's most-quoted starter protocol in DM: "250 mcg/day subcutaneous at bedtime, advance to 500 mcg-1 mg/day during the 6-8 week loading phase, then drop to 500 mcg 2x/week for maintenance."

Protocol500 mcg - 1 mg SubQ during loading, 500 mcg 2-3× per week on maintenance
Frequencydaily during loading, 2-3× per week once tan is established
Durationloading 4-8 weeks, then maintenance for as long as tan is desired. Cycle off in winter when there's no UV to interact with.

Maintenance phase is where MT2 actually pays off, you stop pinning daily and just pin 2-3× per week to hold the tan. Sun exposure (or tanning bed) is still required to keep pigmentation alive, MT2 alone in a windowless room won't hold a tan. Most users find 500 mcg twice weekly is the sweet spot for hold.

Protocol1 mg SubQ during aggressive loading, 500 mcg-1 mg 1-2× per week maintenance
Frequency1 mg daily during a short 2-3 week aggressive loading phase, then maintenance
Durationongoing seasonal, with planned off-cycles to let MC1R reset and to monitor moles

Advanced users running MT2 seasonally for several years know their personal loading floor (some hit deep tan at 250 mcg, some need 1 mg) and time the cycle to start ~6 weeks before expected sun exposure peaks (spring break, summer holiday, beach trip). Long-term heavy users get noticeable mole darkening, freckle deepening, and sometimes new freckle formation, which is the cosmetic signal that systemic melanocortin exposure is meaningful. This is also why annual dermatology check-ins are the smart practice for advanced users, not because MT2 causes melanoma but because it makes baseline mole monitoring harder.

What To Expect
1-2 weeks
First pigmentation signal with uv exposure
libido bump same-day
noticeable change
Side Effects

Straight talk - what people actually report, and what the studies measured.

What users report
From forums, Discord & TikTok
  • Nausea: dominant first-dose complaint, mostly resolves by dose 3-5. Community standard mitigation is bedtime dosing (sleep through it), 250 mcg start dose, and dosing on an empty or light stomach
  • - Divergence: literature pegs nausea at 50-70% in trials, community reports closer to 80-90% of first-timers feel some nausea but the rapid tachyphylaxis means it's almost never a long-term retention issue (unlike PT-141 where first-dose nausea drops more people permanently)
  • Flushing / face going red: very common during loading, "tomato face" 30-90 min post-dose, settles after 1-2 weeks
  • Mole darkening / freckle deepening: universal at meaningful doses, becomes visible within 2-4 weeks of loading. Community treats this as a normal signal but flags any new asymmetric or irregular moles
  • Spontaneous erections / increased libido: reported as a "side effect" by tan-focused users and the "main effect" by those running MT2 primarily for sexual response. Persistent ambient libido bump for 24-48 hours post-dose
  • Decreased appetite: noticeable enough during loading that some users describe a 5-10 lb weight loss as a side bonus
  • Lip and gum darkening: dose-dependent cosmetic signal, usually reversible
  • Eye color or pupil-area pigmentation: rare reports, debated
What the studies show
Measured in clinical trials
  • Nausea: 50-70% in small phase 1 studies (Levine et al, Arizona, 1991) - mostly first-dose, tachyphylaxes within 3-5 doses
  • Flushing: ~40-50% in early studies - transient, 30-90 minutes post-dose, more pronounced in fair skin
  • Decreased appetite: 20-30% reported in early studies - melanocortin pathway crossover with MC4R appetite signaling; usually transient
  • Spontaneous erections in men: documented signal even in pure tanning trials, ~30-40% of male participants in Hadley/Dorr studies
  • Hyperpigmentation of moles, freckles, lips, gums, nipples: dose-dependent, develops over weeks to months of use, partially reversible after discontinuation
  • New nevi (mole) formation: reported in case series of long-term users
  • Yawning: characteristic melanocortin agonism signature
  • Case reports of melanoma in heavy long-term MT2 users (Cardones & Grichnik 2009, Langan et al 2009): causation NOT established, but the safety debate centers on whether MT2 accelerates transformation of existing atypical nevi or just makes them harder to monitor visually
The Research

Peer-reviewed studies and clinical guidelines - tap any to read the source.

PubMedLevine N et al, Induction of skin tanning by subcutaneous administration of a potent synthetic melanotropin, JAMA 1991

original Hadley/Levine UA Tucson phase 1 in humans, established 250-500 mcg dose-response

Read study ↗
PubMedDorr RT et al, Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study, Life Sci 1996

early human PK and AE profile, documented spontaneous erections

Read study ↗
PubMedHadley ME, Discovery that a melanocortin regulates sexual functions in male and female humans, Peptides 2005

Hadley's retrospective on MC4R sexual effect discovery from MT2 research

Read study ↗
PubMedCardones AR, Grichnik JM, alpha-Melanocyte-stimulating hormone-induced eruptive nevi, Arch Dermatol 2009

eruptive nevi case report on MT2 user

Read study ↗
PubMedLangan EA et al, Melanotropic peptides: more than just 'Barbie drugs' and 'sun-tan jabs'?, Br J Dermatol 2010

melanoma case series and safety review

Read study ↗
PubMedHabbema L et al, Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review, Int J Dermatol 2017

comprehensive AE review including PRES, rhabdomyolysis case reports

Read study ↗
+ 5 more studies & references
From The Community

Aggregated sentiment from public forums & socials - real-world reports, not individual endorsements.

Rr/Melanotan dosing

Nausea: dominant first-dose complaint, mostly resolves by dose 3-5. Community standard mitigation is bedtime dosing (sleep through it), 250 mcg start dose, and dosing on an empty or light stomach

Rr/Peptides MT2 protoco

- Divergence: literature pegs nausea at 50-70% in trials, community reports closer to 80-90% of first-timers feel some nausea but the rapid tachyphylaxis means it's almost never a long-term retention issue (unlike PT-141 where first-dose nausea drops more people permanently)

TTanning

Flushing / face going red: very common during loading, "tomato face" 30-90 min post-dose, settles after 1-2 weeks

TTikTok #melanotan and

Mole darkening / freckle deepening: universal at meaningful doses, becomes visible within 2-4 weeks of loading. Community treats this as a normal signal but flags any new asymmetric or irregular moles

Rr/Melanotan loading vs

Spontaneous erections / increased libido: reported as a "side effect" by tan-focused users and the "main effect" by those running MT2 primarily for sexual response. Persistent ambient libido bump for 24-48 hours post-dose

Rr/Melanotan dosing

Decreased appetite: noticeable enough during loading that some users describe a 5-10 lb weight loss as a side bonus

Common Questions
SubQ injection. 250 mcg SubQ daily during loading phase
1-2 weeks for first pigmentation signal with UV exposure; libido bump same-day
A popular pairing is MT2 + PT-141. See the Protocols section, or ask us for a stack built around your goal.
Yes. Every batch is third-party lab tested - request the COA on Telegram and we send it over.
Safety & Contraindications

Hard stops

  • Personal history of melanoma or other skin cancer
  • Atypical mole syndrome (FAMMM) or strong family history of melanoma
  • Active suspicious skin lesions or undiagnosed pigmented lesions
  • Pregnancy or actively trying to conceive
  • Children / adolescents (still-developing melanocortin axis)
  • Active eating disorder (appetite-suppression effect makes restrictive ED worse)
  • Uncontrolled hypertension (transient BP rise during loading)

Caution flags

  • Fair skin, red hair, low MC1R baseline (Fitzpatrick I-II): higher melanoma risk baseline, MT2 amplifies that population's mole activity most visibly
  • Heavy mole burden, even without diagnosed atypia: baseline dermatology mole-mapping before starting is the smart practice
  • History of skin cancer in first-degree relatives
  • Controlled hypertension on medication: monitor BP, especially first 1-2 weeks
  • Concurrent immunosuppression (transplant patients, biologics): skin cancer surveillance is already compromised
  • First-time melanocortin exposure: start at 250 mcg, dose at bedtime

Stacking conflicts

  • Do NOT same-day full-dose stack with PT-141: receptor overlap (MC4R) amplifies nausea, flushing, and BP signal. Alternating days or microdosing one is workable.
  • Caution with stimulants (high-dose caffeine, ADHD meds) during loading: BP and HR can stack
  • Caution with other appetite-suppressing peptides (GLP-1 class) during loading: appetite drop can compound to clinically meaningful weight loss
Is It Right For You?

✓ Good fit

  • fair-skinned users wanting deeper/easier tan
  • frequent burners who want pigmentation protection before sun exposure
  • customers asking about "tan from a peptide"
  • customers wanting tan + libido combo
  • vacation prep / beach trip prep (start 4-6 weeks out)
  • seasonal cyclers

✗ Not a fit

  • melanoma history or family history
  • heavy atypical mole burden
  • dark skin baseline (already at MC1R ceiling, minimal benefit)
  • pregnancy or conception window
  • ED history
  • fitzpatrick I with no dermatology baseline
  • anyone wanting PT-141-style acute sexual response without the tan and pigmentation commitment (route them to PT-141)

Administration & Storage

Route: SubQ injection

Injection site: lower abdomen, outer thigh, or love-handle pinch. Rotate sites. Pinch-and-pin, 90-degree, standard SubQ technique.

Storage: refrigerated, stable 30-45 days reconstituted. Unmixed vials are stable at room temp short-term; refrigerate for long storage. Light-sensitive, keep in original box or wrapped.

Notes: Pin shortly before UV exposure (within 30-60 minutes of going outside or hitting a tanning bed) since UV is what actually triggers the pigmentation cascade. Pinning indoors with no sun exposure burns through the compound without building tan. Bedtime dosing is a community standard for the nausea reason (sleep through it), but bedtime + no morning sun is suboptimal for tan building. Compromise is bedtime dosing during loading, then re-time to pre-sun once nausea has tachyphylaxed.

All products sold for research purposes only. Not for human or animal consumption. Must be 21 or older to purchase. By placing an order you confirm compliance with all applicable local laws and regulations.